In the CCLE dataset, 40% of blood cancer‐derived cell lines carry homozygous TCAB1 deletion, and there was a highly significant reduction of TCAB1 expression in these cell lines (Fig. 6A). The gene discussed is WRAP53; the disease is hematopoietic and lymphoid system neoplasm.